Przychodnia Lekarska "KOMED"; Roman Karaszewski
- Address
- Ul. Wojska Polskiego 6, 62-500 Konin, Poland
Przychodnia Lekarska KOMED - Head and Neck Cancer Research
Przychodnia Lekarska KOMED, under the leadership of Roman Karaszewski, is a clinical research facility specializing in advanced oncology trials. The center focuses on innovative therapeutic approaches for challenging malignancies, with particular expertise in head and neck cancers and immunotherapy combinations.
- Head and Neck Squamous Cell Carcinoma (HNSCC) treatment protocols
- First-line immunotherapy combination studies with PD-L1 checkpoint inhibitors
- Novel biologic agents in recurrent and metastatic cancers
The center is actively engaged in Phase 2/3 clinical trials evaluating combination therapies for recurrent or metastatic head and neck squamous cell carcinoma. Their research portfolio includes studies of innovative agents such as INBRX-106 combined with pembrolizumab in patients with high PD-L1 expression, representing cutting-edge approaches to improving outcomes in this difficult-to-treat patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 77 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 74 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
- 1BioNTech SE2active
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merck Sharp & Dohme LLC9trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Przychodnia Lekarska "KOMED"; Roman Karaszewski
lock Showing 1 of 31 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Randomized, Open-Label Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-Resistant Prostate Cancer (TAMARACK) | Macrogenics Inc. | Phase II | Not Recruiting | May 2023 | Jan 2025 |
IMP list
lock Showing 1 of 77 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 17 | Unknown | 2017-06-08 | 2026-04-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.